[{"address1": "15825 Shady Grove Road", "address2": "Suite 135", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "410-297-7793", "website": "https://ostherapies.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul A. Romness M.P.H.", "age": 57, "title": "Founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert G. Petit Ph.D.", "age": 63, "title": "Chief Medical Officer & Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 300000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher P. Acevedo", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jack  Doll", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald E. Commissiong", "age": 41, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.12, "open": 4.08, "dayLow": 3.8864, "dayHigh": 4.1364, "regularMarketPreviousClose": 4.12, "regularMarketOpen": 4.08, "regularMarketDayLow": 3.8864, "regularMarketDayHigh": 4.1364, "forwardPE": 2.7210884, "volume": 24035, "regularMarketVolume": 24035, "averageVolume": 374812, "averageVolume10days": 100280, "averageDailyVolume10Day": 100280, "bid": 3.95, "ask": 4.09, "bidSize": 1000, "askSize": 800, "marketCap": 83538400, "fiftyTwoWeekLow": 2.51, "fiftyTwoWeekHigh": 4.9, "fiftyDayAverage": 3.6695833, "twoHundredDayAverage": 3.6695833, "currency": "USD", "enterpriseValue": 102647752, "floatShares": 16528053, "sharesOutstanding": 20884600, "sharesShort": 8931, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.24836001, "shortRatio": 0.01, "bookValue": -4.517, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -6549780, "trailingEps": -0.32, "forwardEps": 1.47, "enterpriseToEbitda": -32.233, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "OSTX", "underlyingSymbol": "OSTX", "shortName": "OS Therapies Incorporated", "longName": "OS Therapies Incorporated", "firstTradeDateEpochUtc": 1722519000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "811dc150-e1bb-3134-8d56-2ee3cb92552b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.0, "targetHighPrice": 21.0, "targetLowPrice": 9.0, "targetMeanPrice": 15.0, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 94925, "totalCashPerShare": 0.005, "ebitda": -3184569, "totalDebt": 16698231, "quickRatio": 0.003, "currentRatio": 0.047, "operatingCashflow": -3270649, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]